* UroGen Pharma Chief Medical Officer Mark Schoenberg sold 10,000 ordinary shares on July 9 at a weighted average price of **$40**. * His direct holding fell to 119,763 ordinary shares following the transaction.
URGN•URGN•URGN•URGN•
